Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia

Stopped Overall profile of the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents

Conditions

• Hypercholesterolemia

Interventions

• DRUG: Lapaquistat acetate
• DRUG: Placebo

Sponsor

Takeda